Algert Global’s Alpine Immune Sciences Inc ALPN Stock Holding History

Algert Global’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-108,841	Closed	-$4.31M	–	1606
2024 Q1	$4.31M	Buy	108,841 +80,551	+285%	+$2.38M	0.17%	197
2023 Q4	$539K	Buy	28,290 +8,280	+41%	+$115K	0.02%	804
2023 Q3	$229K	Buy	+20,010	New	+$246K	0.01%	943

Algert Global's ALPN Position: Q2 2024 in Review

Algert Global sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 108,841 shares — an estimated $4.31M sold.

Algert Global first reported a position in ALPN in Q3 2023 and held it in 3 quarters. The position peaked at $4.31M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Algert Global reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Algert Global sold 108,841 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $4.31M.
Algert Global first reported a position in Alpine Immune Sciences Inc in Q3 2023 and held it in 3 quarters.
Algert Global's Alpine Immune Sciences Inc position peaked at $4.31M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Algert Global's 13F filing for Q2 2024, filed 15 Aug 2024.